Maybe you lost five pounds in three months while your neighbor dropped thirty
Always verify coverage with your insurance provider
However, 48% of patients discontinued Semaglutide due to gastrointestinal discomfort
Together, these studies support ongoing pharmacotherapy whether injectable or oral rather than discontinuation for patients who have achieved meaningful weight loss
Anyone with a history of pancreatitis, serious stomach or gallbladder disease, or a family history of certain thyroid cancers needs especially careful medical review before using tirzepatide or semaglutide, since both drugs affect gut hormones and digestion, and people on insulin or sulfonylureas must watch for low blood sugar, while those with significant kidney disease or severe gastrointestinal symptoms may need slower titration, alternative medications, or more frequent monitoring, so an honest conversation with an experienced prescriber and a full medication list is critical before starting or switching
We serve Fort Worth, Denton, Frisco, Plano, Denison, and surrounding communities
